Childhood Narcolepsy: Recent Advances in Treatment

Medically Reviewed by Brunilda Nazario, MD on December 03, 2025
6 min read

By Craig Canapari, MD, as told to Keri Wiginton

If your child has narcolepsy, you probably searched for answers for a long time. This isn’t something that usually gets identified or treated quickly, 

but that’s starting to change. We’re spotting it earlier, and the medication choices for kids have grown in the past few years.

As a pediatric sleep specialist at Yale Medicine, I see how much relief families feel when everything finally makes sense. Once we understand what’s going on, we can focus on what helps: the right medicine, healthy sleep habits, and strong support at school and at home.

Here’s how I guide families through narcolepsy care today, what’s new, and how recent advances can make daily life easier.

Like with other pediatric sleep disorders, there aren’t as many FDA-approved medicines for kids with narcolepsy as there are for adults. But we still have several choices that work well, including: 

  • Modafinil (provigil)
  • Pitolisant (Wakix)
  • Sodium oxybate (Lumryz, Xyrem, Xywav)

Each medicine works in a different way. I choose the best fit based on a child’s age, daily needs, and symptoms. 

If your child has type 1 narcolepsy, they may also have cataplexy. Cataplexy is sudden muscle weakness usually triggered by strong emotions. It tends to happen when a child laughs, gets excited, or is scared or startled suddenly.

Cataplexy in young children may look different from what we see in older kids. Their jaws may suddenly go slack, or their tongues may push up. Teachers sometimes think the child is making faces on purpose.

These episodes happen because the brain is mixing up the borders between sleep and wake. During REM sleep, the muscles are briefly paralyzed. In cataplexy, REM paralysis shows up while a child is awake. 

The mix-ups can go the other way too. Kids may have sleep paralysis or dream-like hallucinations as they fall asleep or wake up. These are all signs that the REM system is unstable.

Medicines like sodium oxybate and pitolisant help by strengthening the boundary between REM sleep and wakefulness. They make sleep more stable at night and reduce REM-related symptoms during the day.

For children with type 2 narcolepsy, medicines that mainly target daytime sleepiness, like modafinil, may be enough.

 

 

Modafinil is a wake-promoting agent. It helps the brain stay alert so kids can stay awake in class and get through the day. It acts a bit like a stimulant, but it’s not one in the traditional sense. So it doesn’t cause the same appetite loss you see with ADHD medicines like methylphenidate or amphetamines.

Kids usually take modafinil twice a day, once in the morning and again around lunchtime. Most handle it well, and it tends to be affordable with insurance or discount programs. (Armodafinil is a related medicine taken once a day. It isn’t FDA-approved for people under 18.)

There are two key side effects I always mention: a birth control issue and a rare rash. 

Modafinil can make birth control pills less effective, so teens who use them for pregnancy prevention need a backup method. And in very rare cases, it can cause a serious allergic reaction called Stevens-Johnson syndrome. 

If a child develops a widespread rash while taking it, we stop the medicine right away.

Sodium oxybate can be life-changing for the right child. It improves nighttime sleep, reduces cataplexy, and helps many kids wake up feeling more rested. It’s FDA-approved for children 7 and up.

But I rarely start with sodium oxybate for two reasons:

It’s very strong. This medicine makes people sleep very deeply. Kids need at least seven to eight hours of sleep when they take it. So if they go to bed late and need to wake up early for school, this medicine will not work well for them. They’ll feel awful in the morning.

Some forms require a dose in the middle of the night. Older versions (Xyrem and Xywav) need a second dose a few hours after the first. Teens rarely wake up reliably, so parents often have to wake them. That disruption can take a toll on families.

The newest version, Lumryz, is a once-nightly sodium oxybate. It’s a big advance. But not all insurance plans cover it yet, and some kids still do better on split dosing.

What about salt and long-term health?

The older formula, Xyrem, contains a lot of sodium. For long-term use, that may raise blood pressure over decades. Xywav has far less sodium than  Lumryz or Xyrem, so I usually start there if we’re using this class of medicine.

 

 

Pitolisant (Wakix) is FDA-approved down to age 6. It works on histamine. That’s one of the neurological systems that helps regulate wakefulness. This drug improves both sleepiness and cataplexy, and it’s taken once each morning.

The main challenge is cost. It can be expensive, and some insurance plans require prior authorization. But when families can access it, it can be a helpful option, especially for kids with type 1 narcolepsy.

When families finally get a narcolepsy diagnosis, they often ask me things like: 

  • Is this medicine safe?
  • Will my child need it forever?
  • Is there a cure?
  • How will narcolepsy change my child’s future?

These are all reasonable questions. Here’s what I want you to know: 

Wakefulness-promoting drugs aren’t addictive. Kids don’t get high from them, and they don’t misuse them in my experience. Even traditional stimulants tend to be used responsibly by the children I treat. 

Your child may need treatment long-term. But the plan probably won’t stay the same, and doses can change. We adjust as their body grows, their schedule changes, and as new medicines come out.

The right treatment can dramatically change daily life. When we get sleepiness under control, kids think more clearly, stay on track in school, and have more confidence. I’ve seen students go from struggling to stay awake in class to keeping up — and sometimes excelling — once we find the right plan. 

Complete care includes emotional support. Narcolepsy can feel isolating or confusing. Some kids are embarrassed about their symptoms or don’t want friends to know. We often involve psychologists or social workers to help kids adjust. Peer support can also make a real difference.  

I also talk with families about what may be coming next. Research is moving quickly, and new treatments are on the horizon. 

One of the most exciting developments is the rise of orexin agonists. Those are drugs designed to replace or mimic hypocretin (also called orexin). That’s a sleep-wake regulating chemical missing in most kids with type 1 narcolepsy.

These drugs are still being studied, and most research is in adults. But if early results hold up, they may become the first treatment to directly target the cause of type 1 narcolepsy. Pediatric testing always comes later, but I’m hopeful these medicines will eventually expand our options for children.

Right now, there are no gene therapies or immune-based treatments in clinical trials. But research is ongoing, and the field is moving faster than it did even a decade ago.